Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Pembrolizumab, Temozolomide and HSPPC-96 Vaccine in Newly Diagnosed Glioblastoma Post-Chemoradiation: Results from a Multi-institutional, Phase 2, Randomized, Placebo-Controlled Trial.
Journal: medRxiv : the preprint server for health sciences
Published: July 03, 2026
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 07, 2023
A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma.
Journal: Neuro-oncology
Published: March 14, 2020
Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma.
Journal: Neuro-oncology
Published: May 05, 2017
A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients.
Journal: Journal of neuro-oncology
Published: August 05, 2015
Intravenous thrombolysis for ischemic stroke in recurrent oligodendroglioma: a case report.
Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
Published: June 13, 2013
Initial treatment patterns over time for anaplastic oligodendroglial tumors.
Journal: Neuro-oncology
Published: June 05, 2012
Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study.
Journal: Journal of neuro-oncology
Published: November 08, 2011
Showing 1-12 of 12
Last Updated: 09/26/2026